Notice: This company has been marked as potentially delisted and may not be actively trading. Medicis Pharmaceutical (MRX) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesOptions ChainTrends Medicis Pharmaceutical Latest Earnings SummaryUpcoming Q4 Earnings DateApr. 28EstimatedActual EPS (Nov. 7) $0.76 Beat By $0.08 Consensus EPS (Nov. 7) $0.68 Medicis Pharmaceutical announced Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.76, which beat analysts' consensus estimates of $0.68 by $0.08. Quarterly revenue rose 31.9% year-over-year to $391.20 million, above the consensus estimate of $378.62 million. With a trailing EPS of $0.00, Medicis Pharmaceutical's earnings are expected to decrease -0.34% next year, from $2.93 to $2.92 per share. Conference Call AudioEarnings Press ReleaseEarnings Slide DeckMRX Upcoming EarningsMedicis Pharmaceutical's next earnings date is estimated for Monday, April 28, 2025, based off prior year's reporting schedules. Get Medicis Pharmaceutical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicis Pharmaceutical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Medicis Pharmaceutical Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$2.93 EPSNext Year EPS Consensus Estimate: $2.92 EPS Medicis Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 4/28/2025(Estimated)------- 11/7/2024Q3 2024$0.68$0.76+$0.08$0.79$378.62M$391.20M 8/14/2024Q2 2024$0.53$0.90+$0.37$1.04$351.91M$422.10M Medicis Pharmaceutical Earnings - Frequently Asked Questions When is Medicis Pharmaceutical's earnings date? Medicis Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 28th, 2025 based off last year's report dates. Learn more on MRX's earnings history. Did Medicis Pharmaceutical beat their earnings estimates last quarter? In the previous quarter, Medicis Pharmaceutical (NYSE:MRX) reported $0.76 earnings per share (EPS) to beat the analysts' consensus estimate of $0.68 by $0.08. Learn more on analysts' earnings estimate vs. MRX's actual earnings. How can I listen to Medicis Pharmaceutical's earnings conference call? The conference call for Medicis Pharmaceutical's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Medicis Pharmaceutical generate each year? Medicis Pharmaceutical (NYSE:MRX) has a recorded annual revenue of $1.24 billion. How much profit does Medicis Pharmaceutical generate each year? Medicis Pharmaceutical (NYSE:MRX) has a recorded net income of $141.30 million. MRX has generated $0.00 earnings per share over the last four quarters. What is Medicis Pharmaceutical's EPS forecast for next year? Medicis Pharmaceutical's earnings are expected to decrease from $2.93 per share to $2.92 per share in the next year, which is a -0.34% change. ` More Earnings Resources from MarketBeat Related Companies BGC Group Earnings StoneX Group Earnings Forge Global Earnings Intercontinental Exchange Earnings CME Group Earnings Nasdaq Earnings Tradeweb Markets Earnings T. Rowe Price Group Earnings LPL Financial Earnings RLI Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! This page (NYSE:MRX) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicis Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
